利用基线MRI通过深度学习预测PET脑血管储备:一项无药物脑负荷试验的初步研究
本研究回顾性分析2017年4月至2019年5月间烟雾病患者的同期15O-水PET/MRI(注射乙酰唑胺前后),训练深度学习模型仅用基线影像预测乙酰唑胺诱导的相对脑血流量变化图。两种模型(PET联合MRI模型和仅MRI模型)预测图像质量优于ASL,与PET相关性更高,识别灌注受损血管区域的AUC均为0.95。
要点
- 仅用乙酰唑胺给药前的基线MRI,深度学习模型即可预测脑血管储备图像,无需注射血管扩张剂。
- 预测的rΔCBF图图像质量指标均优于ASL(患者中P < .001),与PET的相关系数高于ASL。
- 识别rΔCBF受损血管区域:PET联合MRI模型AUC 0.95(95%CI: 0.90, 0.99),仅MRI模型AUC 0.95(95%CI: 0.91, 0.98)。
研究设计与样本
- 回顾性分析2017年4月至2019年5月间接受乙酰唑胺注射前后同期15O-水PET/MRI的患者,包括24例烟雾病患者(平均年龄±标准差,41岁±12;17例女性)和12例年龄匹配的健康对照(平均年龄,39岁±16;九例女性)。
- 深度学习模型输入为灌注图像(动脉自旋标记[ASL])、结构扫描(T2液体衰减反转恢复、T1)和脑位置。
- 两种模型(乙酰唑胺给药前的15O-水PET脑血流量[PET联合MRI模型]和乙酰唑胺给药前的仅MRI[仅MRI模型])经六折交叉验证进行训练和测试。
- 模型学习预测体素级相对脑血流量变化(rΔCBF)图,以PET测得的乙酰唑胺所致rΔCBF作为参考标准。
诊断标准与关键数值
- 两种深度学习模型预测的rΔCBF图图像质量指标(峰值信噪比、均方根误差、结构相似性指数)均优于ASL(患者中所有P < .001)。
- 预测rΔCBF图与PET的相关系数:PET联合MRI模型0.704,仅MRI模型0.690,ASL 0.432;两种模型均高于ASL(患者中均P < .001)。
- 识别rΔCBF受损血管区域的AUC:PET联合MRI模型0.95(95%CI: 0.90, 0.99),仅MRI模型0.95(95%CI: 0.91, 0.98)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Cerebrovascular reserve (CVR) may be measured by using an acetazolamide test to clinically evaluate patients with cerebrovascular disease. However, acetazolamide use may be contraindicated and/or undesirable in certain clinical settings. Purpose To predict CVR images generated from acetazolamide vasodilation with a deep learning network by using only images before acetazolamide administration. Materials and Methods Simultaneous oxygen 15 (15O)-labeled water PET/MRI before and after acetazolamide injection were retrospectively analyzed for patients with Moyamoya disease and healthy control participants from April 2017 to May 2019. Inputs to deep learning models were perfusion-based images (arterial spin labeling [ASL]), structural scans (T2 fluid-attenuated inversion-recovery, T1), and brain location. Two models, that is, 15O-labeled water PET cerebral blood flow (CBF) and MRI (PET-plus-MRI model) before acetazolamide administration and only MRI (MRI-only model) before acetazolamide administration, were trained and tested with sixfold cross-validation. The models learned to predict a voxelwise relative CBF change (rΔCBF) map by using rΔCBF measured with PET due to acetazolamide as ground truth. Quantitative analysis included image quality metrics (peak signal-to-noise ratio, root mean square error, and structural similarity index), as well as comparison between the various methods by using correlation and Bland-Altman analyses. Identification of vascular territories with impaired rΔCBF was evaluated by using receiver operating characteristic metrics. Results Thirty-six participants were included: 24 patients with Moyamoya disease (mean age ± standard deviation, 41 years ± 12; 17 women) and 12 age-matched healthy control participants (mean age, 39 years ± 16; nine women). The rΔCBF maps predicted by both deep learning models demonstrated better image quality metrics than did ASL (all P < .001 in patients) and higher correlation coefficient with PET than with ASL (PET-plus-MRI model, 0.704; MRI-only model, 0.690 vs ASL, 0.432; both P < .001 in patients). Both models also achieved high diagnostic performance in identifying territories with impaired rΔCBF (area under receiver operating characteristic curve, 0.95 for PET-plus-MRI model [95% confidence interval: 0.90, 0.99] and 0.95 for MRI-only model [95% confidence interval: 0.91, 0.98]). Conclusion By using only images before acetazolamide administration, PET-plus-MRI and MRI-only deep learning models predicted cerebrovascular reserve images without the need for vasodilator injection. © RSNA, 2020 Online supplemental material is available for this article.
引用
- Chen DYT, Ishii Y, Fan AP, et al. Predicting PET Cerebrovascular Reserve with Deep Learning by Using Baseline MRI: A Pilot Investigation of a Drug-Free Brain Stress Test. Radiology. 2020. PMID: 32662761. doi:10.1148/radiol.2020192793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。